Hemostatic procedures in gastric endoscopic submucosal exfoliation (ESD)

Hemostatic procedures in gastric endoscopic submucosal exfoliation (ESD) - Hemostatic procedures in gastric endoscopic submucosal exfoliation (ESD)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000052773

Enrollment

Registered

2023-11-13

Start date

2023-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients who underwent gastric ESD at our department during the eligible period

Interventions

In the first half of the period, the effectiveness of the conventional hemostatic method using hemostatic forceps (number of coagulation hemostasis and size of ulcer base of post-treatment ulcer 1 and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who underwent gastric ESD in our department from September 2023 (after Ethics Committee approval) to April 2024 will be included.

Exclusion criteria

Exclusion criteria: Patients who did not give consent for clinical research.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the frequency of posterior hemorrhage. Secondary endpoints are the number of coagulation hemostasis at second-look endoscopy and the size of the ulcer base of the posttreatment ulcer at 1 and 2 months after ESD.	—

Countries

Japan

Contacts

Public ContactNaoki Aaayama

Department of Gastroenterology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima Department of Gastroenterology

asayama0502@hiroshima-u.ac.jp082-815-5211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026